Background: Smoking is associated with an increased risk of oral health and dental problems. The aim of this study is to address the hypothesis that nicotine impairs wound healing by increasing reactive oxygen species and inhibiting cell migration, and antioxidants (AOs) may counteract nicotine effects.
P eriodontal tissues are vulnerable to various types of reactive oxygen species (ROS) from dental restorative procedures and the environment. One of the most common chemical insults to the oral tissue is nicotine (Nic). Studies by Fang and Svoboda 1,2 demonstrated that Nic decreased gingival fibroblast migration, signaling molecules, and altered the response to transforming growth factor-beta 1 (TGF-b1) by decreasing the morphologic change from fibroblast to myofibroblast cells. These studies 1, 2 supported the theory that Nic interferes with wound closure by changing the ability of oral fibroblasts to contract wounds.
Smoking is associated with an increased risk for poor oral health and dental problems. A recent study 3 showed that cigarette smoking was one of the risk factors involved in the development and progression of periodontal disease. Smoking promotes a high degree of ROS release that results in heightened oxidative damage to gingival tissues, periodontal ligaments (PDLs), and alveolar bone. 4 Previous studies have documented the effects of smoking including persistent gingival bleeding, 5 vertical bone loss, 6 and poor treatment outcomes. 7 Similarly, an in vitro study 8 showed that Nic had inhibitory effects on the attachment and growth of gingival and PDL fibroblasts. A clinical study 9 showed that chemical substances in tobacco can slow down the healing process and affect results after periodontal treatment or oral surgery. All tobacco products can increase the growth and development of oral cancer, halitosis, stained teeth, bone loss, taste loss, periodontal treatment failure, dental implant failure, gingival recession, mouth sores, and facial wrinkling. 10 These studies [3] [4] [5] [6] [7] [8] [9] [10] evaluated the mode of action that tobacco smoking uses to affect oral health. In addition to an increase in ROS formation, smoking may also decrease antioxidant (AO) levels. It was theorized that treatment with AOs may block the production of ROS or block their effects and may be therapeutically valuable in reducing the risk for many dental maladies. 11 A dose-response decrease in the salivary and gingival crevicular fluid superoxide dismutase levels was found in light smokers and heavy smokers compared to non-smokers. 12 A significant reduction in the serum levels of vitamin C and other nonenzymatic AOs such as vitamin A and E and coenzyme Q10 was found among smokers.
Nic is a drug that affects every individual through direct contact or secondhand inhalation. 13 Song et al. 14 used a cotinine urine test for smoking-status determination. Cotinine is the first-stage metabolite of Nic that is a toxic alkaloid that produces stimulation of the autonomic ganglia and the central nervous system in humans. Song et al. 14 found high levels of urine cotinine in non-smokers, illustrating the seriousness of passive smoking exposure.
At the cellular level, the protein content was significantly decreased, and cell membranes were damaged in the presence of Nic. 15 Morphologic alterations of cytoskeletal elements, microtubules, and vimentin were observed at Nic concentrations >3.9 mM. 16 Nic-exposed cells had atypical shapes and vacuoles and decreased fibroblast growth at concentrations >7.8 mM. The toxic effects of Nic became irreversible between 10.5 and 15.5 mM, whereas, at lower concentrations, cells recovered after Nic withdrawal. 16 In addition, Fang and Svoboda observed that Nic decreased cell-signaling molecules in cultured gingival fibroblast cells 1 and decreased TGF-b1-stimulated transformation from fibroblast to myofibroblast cells, 2 supporting the theory that Nic interferes with wound closure by changing the gingival fibroblast ability to contract wounds.
Human PDL (HPDL) cells responded to Nic and tobacco extracts nearly the same as human gingival fibroblasts (HGFs) by changing morphology and structure with decreased growth and attachment through cytoskeletal disruption. 17 In experiments that used HPDL-cell attachment to periodontal diseased or healthy roots, PDL cells of smokers had a significant reduction in attachment to roots compared to nonsmokers. 18 Cells were flattened in the control groups, whereas they were rounded in the smoker groups, indicating a change in the actin cytoskeleton structure. 18 The investigators 18 suggested that cigarette smoking compromises PDL-cell adhesion to root surfaces, which may affect periodontal regeneration following therapy.
The aim of the present study is to address the hypothesis that Nic impairs wound healing by inhibiting cell migration, and AOs may counteract Nic effects. In this study, we tested the effects of bioactive AO mixtures on two types of fibroblasts derived from HGF and HPDL tissues. The potential benefits of the bioactive AOs tested (resveratrol [R], ferulic acid [F], phloretin [P] , and tetrahydro-curcuminoids Cockroft Gault [T]) were chosen because they were used to prevent or counteract cellular damage, cancer, aging, and other diseases. Beneficial effects attributed to these compounds include an AO, antiangiogenic, anti-inflammatory, antiviral, and antitumor properties. 19 R had potent effects on apoptosis in HPDL cells. 20 F was effective in inhibiting lipid peroxidation in rat-liver microsomal membranes and ROS production in the National Institute of Health 3-day transfer (NIH3T3) fibroblasts induced by both 2,2-azobis(2-amidinopropane) and tert-butyl hydroperoxide. 21 22 Curcumin has a role in idiopathic pulmonary disease (IPF) that is characterized by excessive collagen deposition associated with dysregulated wound healing. Curcumin effectively reduces profibrotic effects in normal and IPF fibroblasts in vitro, and this reduction is accompanied by the inhibition of key steps in the TGF-b signaling pathway. 23 We theorized that the use of these AOs may stimulate HGFs and HPDLs to migrate and undergo a variety of cellular changes that would occur during in vitro wound healing.
Rac is an Rho-family small GTPase that participates in cell signaling in migrating cells. 24 These proteins cycle between active (guanosine triphosphate [GTP]-bound) and inactive (guanosine diphosphate [GDP]-bound) states. The activated, GTP-bound form of Rac is associated with cell motility, and is an indicator of cell-migration ability. 24, 25 It is also known that Nic decreases cell migration, and we tested the hypothesis that RacGTP is decreased in the leading edge of Nictreated cells. We further propose that AOs promote cell migration indirectly by contributing to the activation of RacGTPases and may counteract the downregulation of RacGTP in Nic-treated cells. We tested the hypothesis by using live-cell imaging and cell-migration quantification and determined if the leading edge cells express RacGTP.
MATERIALS AND METHODS

Cell-Culture Preparations
Human gingival tissues from healthy non-smokers were collected with institutional review board approval by the Baylor School of Dentistry, Texas A&M Health Sciences Center, Dallas, Texas. The tissues were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM), § 10% fetal bovine serum (FBS), i and 1% antimycotic/antibiotic. ¶ Tissues were incubated at 37°C in a humidified gas mixture (5% CO 2 and 95% air), and the medium was changed after 24 hours and every 48 hours thereafter. HGFs grew from the tissue after 1 week. Cells were passaged when they were confluent by using 0.25%-trypsin solutions and plated in new tissue-culture flasks. # Passages three through eight were used in all experiments. HPDL fibroblasts were isolated from freshly extracted human teeth as previously described 26 and used in all experiments. Culture conditions as described for HGFs were similarly used for HPDL cells.
Cell Viability
Briefly, cells were seeded to 96-well flat-bottomed microtiter plates and grown in 0.1 ml per well at 5 · 10 3 cells with DMEM containing 10% FBS in 5% CO 2 . Cells were incubated overnight (to 80% confluence) and serum starved (in 0.1% FBS) for 2 hours before Nic treatment. Thereafter, the media were replaced with DMEM containing 0.1% FBS with various concentrations of Nic (6, 8, or 10 mM)** and incubated for 10 hours. Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) colorimetric assay. † † This quantitative assay detects living cells but not dead ones. After each treatment of Nic, 20 mL MTS reagent was added to each well and incubated for 2.5 hours at 37°C. The absorbance at 490 nm was measured using a microplate spectrophotometer. ‡ ‡ The wells that contained culture medium but no cells served as blanks. HGF experiments had three to six replicate wells per treatment group, and the experiments were repeated three times. HPDL experiments had three to six replicate wells per treatment group, and the experiments were repeated two times.
Cell-Migration Assay
To test the effects of Nic and AO compositions on cell migration, HGF or HPDL cells were grown to confluence in a 35-mm culture dish § § that was divided into four parts and had an incorporated plane parallel top plate (Figs. 1A through 1C) . The plate prevented light-path distortion by the meniscus, and enabled a high-quality phase-contrast observation (Fig. 1B) .
The cells were placed in 0.1% FBS medium and 6 mM Nic for 2 hours. Some samples received 8 or 10 mM Nic. Each quadrant of the plate was used for a different treatment, and four conditions were analyzed in the same time-lapse experiment. Cells were treated with single, double, or triple AOs (R, ii F, ¶ ¶ P, ## and T*** in a 1:1 ratio at a 0.4% weight/volume (w/v) (10 -5 M) ( Table 1) . Cell migration was recorded using a live-cell imaging system † † † every 15 minutes for 10 hours, and the data at 1, 5, or 10 hours are presented. The three to four areas of interest per culture condition were considered for analyses of migration rates.
Immunofluorescence and RacGTP Quantification
Both cell types (HGF and HPDL) were plated at 5 · 10 4 cells per well in a chamber glass slide with a cover. ‡ ‡ ‡ The cells were grown overnight until confluent and pretreated with Nic (6, 8, or 10 mM) for 2 hours and treated with AOs (R, F, T, or P) in double or triple combinations at 0.4% w/v (10 -5 M). Two hours later, a scratch-wound assay was performed using a sterile 10-ml pipette tip. Cells were incubated for 10 hours, fixed with 4% paraformaldehyde for 30 minutes, and prepared for immunohistochemistry as described. 2 The specific primary antibody for RacGTP (at a 1:500 dilution) § § § was placed on the cells overnight at 4°C. The secondary antibody (1:500 goat antimouse immunoglobulin G [IgG] [heavy and light chains]) iii was incubated for 2 hours at room temperature.
The pixel-intensity analysis of RacGTP was determined using confocal microscopy. All treatments were recorded with the same settings on a microscope. ¶ ¶ ¶ All images were taken from projected z stacks of the immunolabeled cells. The pixel intensity of RacGTP was measured using software. ### All fluorescent pixels in a field (representing RacGTP detected from 510 to 530 l) were included in a region of interest (ROI). The software then determined the mean fluorescence intensity within the ROI. A total of four different areas in the image from two experiments (n = 4) were completed for each treatment group.
Statistical Analyses
Data were analyzed using a statistical package**** (the Mann-Whitney U test was used for comparisons). For the live cell-migration plates, each test group was analyzed in three to four areas. P was set at 0.05 and 0.0005. For RacGTP expression, a total of four different areas in the images taken were considered for analysis. P was set at 0.05 and 0.01. For viability assays, a mean of three to six replicates in both cell types for each test group was determined. P was set at 0.05 and 0.01.
RESULTS
Cell-Viability Assay
A dose-dependent analysis was completed to determine the effect of Nic on cell viability. Cell viability decreased as the concentration of Nic increased in HGF (Fig. 1D ) and HPDL (Fig. 1E ) cells. Nic decreased the cell viability by 40% to 50% at all concentrations tested in both cell types. Because of the uniform decrease in cell viability, we chose to use the lowest concentration (6 mM) for migration analysis to minimize the toxic effect on the cells.
Cell-Migration Assay
Control HGF and HPDL cells had a leading edge with many lamellipodia and filopodia and moved steadily across the dish (Figs. 2A through 2C and 3A through 3C) (see supplementary videos V1 and V9 in the online Journal of Periodontology). Cells treated with Nic (6 mM) for 2 hours before in vitro wounding had decreased lamellipodia width and mobility (Figs. 2D through 2F and 3D through 3F) (see supplementary videos V2 through V4 and V10 through V12). The migration distance covered by HGF cells treated with 6 mM Nic was similar to the distance covered by cells treated with higher doses of Nic (compare supplementary videos V2 through V4). We also noticed more inclusion bodies in the phase-contrast images of cells treated with 6 mM Nic (Figs. 2D through 2F) (see supplementary video V2) than in control cells. Cells exposed to high doses of Nic (8 or 10 mM) moved as a sheet with very few lamellipodia extensions (see supplementary videos V3 and V4). The HGF and HPDL Nic-treated cells had significantly less migration than controls (Fig. 2S) . Interestingly, the HPDL cells migrated nearly 40 mm (Fig. 3S ) (see supplementary videos V11 and V12) but were still significantly slower than control cells. These cells also contained many reflective inclusion bodies.
The cells treated with AO compounds increased migration rates compared to controls and cells treated with Nic (6 mM) ( Table 2; Figs. 2S and 3S) (see supplementary videos V5 through V8 and V13 through V16). Only the best compounds and combinations are highlighted in the figures. However, the complete data set is presented in Tables 2 and 3 Table 2 ). However, HPDL cells responded to R with the greatest effect on the lamellipodia extension and advancing the cell's front (Figs. 3G through 3I and supplementary video V13). F-treated HGF cells had Nic-induced vacuoles at the 1-and 5-hour time points (Figs. 2G and 2H) but were decreased by 10 hours (Fig. 2I ), whereas R did not change the Nic-induced vacuoles (Figs. 3G through 3I).
All double combinations were tested in HGF (Table  2 ) and HPDL cells (Table 3 ). For the purposes of discussion, only RF + Nic and PF + Nic will be highlighted. All triple-AO combinations increased HGF-and HPDL-cell movement even more than double combinations ( Table 2 ). For the purposes of a brief discussion, we chose PFR-treated HGFs and RFT-treated HPDLs to highlight. PFR-treated HGF cells had more filopodia than lamellipodia. The filopodia were moving in different directions until forming a network (Figs. 2P through 2R) (see supplementary video V8). In contrast, RFT treated-HPDL cells had numerous fingerlike projections that were freely spreading with each other toward the center (Figs. 3P through 3R) (see supplementary video V16).
As expected, Nic had a deleterious effect on cell migration that increased with exposure to higher concentrations of Nic (Table 2) . Treatment with AOs counteracted the effects of Nic and stimulated cell migration to higher levels than untreated control cells. These increased migration effects were more pronounced at 5 and 10 hours after treatment (Figs. 2S and 3S ). The cells treated with a single AO after Nic treatment (R + Nic, P + Nic, T + Nic, and F + Nic) increased cell migration more than two-fold by 5 hours and almost three-fold by 10 hours ( Fig. 2S ; Table 2 ). Cells treated with a combination of 2 AOs (RT + Nic, RP + Nic, RF + Nic, and FT + Nic) were slightly faster than single-AO treatments ( Fig. 2S ; Table 2 ). However, the best double-AO combinations (PT + Nic and PF + Nic) were nearly the same as triple combinations at the 5-and 10-hour time points ( Fig.  2S ; Table 2 ). Cells treated with a combination of three AOs (RFT + Nic, PFR + Nic, and PFT + Nic) had the fastest migration rates that were over four-fold faster 
Three different combinations of three AOs were applied to gingival fibroblasts to determine the effects of these compositions on HGF migration and to detect any toxic effects that these compositions may have on gingival fibroblasts. HPDL cells were also studied. The first composition tested, designated RFT, was a 1:1:1 by weight ratio composition of R, F, and T. The second composition tested, designated PFR, was a 1:1:1 by weight ratio composition of P, F, and R. The third composition tested, designated PFT, was a 1:1:1 by weight ratio composition of P, F, and T. Compositions were prepared as 40% w/v (total AOs) solutions in DMSO (e.g., a total of 400 mg AOs in a 1-ml total volume) (1.6 · 10 -3 M). Compositions were diluted with DMSO to achieve the lower concentrations of 4% w/v (1.6 · 10 -4 M) and 0.4% w/v (1.6 · 10 -5 M). P was 98.6% pure (molecular weight: 274; Kaden Biochemicals). In compositions containing P, it was present at a concentration of between 4.9 · 10 -3 M for the 40% w/v composition) and 4.9 · 10 -6 M for the 0.4% w/v composition. F was 99% pure (molecular weight: 194; Sigma-Aldrich). In compositions containing F, it was present at a concentration of between 6.8 · 10 -3 M for the 40% w/v composition and 6.8 · 10 -6 M for the 0.4% w/v composition. T was 96.93% pure (molecular weight: 372; Sabinsa). In compositions containing T, they were present at a concentration of between 3.6 · 10 -3 M for the 40% w/v composition and 3.6 · 10 -6 M for the 0.4% w/v composition. R was 98% pure (molecular weight: 228; Lalilab). In compositions containing R, it was present at a concentration of between 5.8 · 10 -3 M for the 40% w/v composition and 5.8 · 10 -6 M for the 0.4% w/v composition. Unless otherwise indicated, concentrations expressed are for the total amount of AOs, not individual AO components. Certain tests were conducted using only two AOs; a 0.25-M solution of each AO was prepared and combined to produce a final solution that had a total of 0.5-M AOs. Similarly, in tests using single AOs, the concentration was 0.5 M for each AO.
than controls and 12-fold faster than the 6-mM Nic treatment. These data demonstrate that combinations of AOs have a greater effect on cell-migration rates than single AOs, but all AOs counteracted the effect of Nic on HGF migration ( Fig.  2S ; Table 2 ).
In (Figs. 2S and 3S ). However, all AO treatments increased the migration distance and counteracted the effects of Nic. Three single-AO treatments (R + Nic, F + Nic, and T + Nic) exceeded control cells, and the cell migration with P + Nic treatment was the same as the control Effect of AOs in HGF-cell migration treated with or without 6 mM Nic. The control HGFs had many lamellipodia and filopodia at the leading edge (white line) and moved steadily across the dish (A through C). Cells treated with Nic (6 mM) for 2 hours before in vitro wounding did not migrate into the wound (D through F). Cells treated with Nic and AOs had many cells moving into the wound bed and included F + Nic (G through I), RF + Nic (J through L), PF + Nic (M through O), and PFR + Nic (P through R). Forward movement was determined with software at 1, 5, and 10 hours (S). At 1 hour (black bars), all AO-treated cells moved more than controls or Nic-treated cells. By 5 hours, clear differences in migration rates were recorded among groups, and by 10 hours, the single (F + Nic) and double (RF + Nic) AO-treated cells moved 80 mm. The PF + Nic-treated group moved as fast as the triple AOtreated cells (PFR + Nic) at over 120 mm. Data from all treatments are presented in Table 2 . Scale bar = 10 mm.
cell migration ( Fig. 3S ; Table  3 ). There was more variation with the double-AO treatments (RF + Nic, RP + Nic, FT + Nic, RT + Nic, PF + Nic, and PT + Nic) with RP + Nic, FT + Nic, and RT + Nic having the greatest migration distance (Table 3 ). In the triple AO-treatment groups, RFT + Nic and PFR + Nic migrated a greater distance than PFT + Nic ( Fig. 3S; Table 3 ). Effect of AOs in HPDL-cell migration treated with or without 6 mM Nic. Control HPDLs contained lamellipodia and filopodia at the leading edge (white line) and moved gradually across the dish and nearly closing the in vitro wound (A through C). Cells treated with Nic (6 mM) for 2 hours had large inclusions and did not move across the substrate (D through F). Cells treated with Nic and AOs had many cells moving into the wound bed and included R + Nic (G through I), RF + Nic (J through L), PF + Nic (M through O), and RFT + Nic (P through R). Forward movement was determined with software at 1, 5, and 10 hours (S). At 1 hour (black bars), all AO-treated cells moved more than controls or Nictreated cells. By 5 hours, clear differences in migration rates were recorded between groups, and by 10 hours, the single-and double AOtreated cells moved 70 mm, and the triple AO-treated cells moved over 100 mm. Data from all treatments are presented in Table 3 . Scale bar = 10 mm. (Figs. 4 and 5) . Nic-treated cells had reduced RacGTP in the leading edge in a dose-dependent pattern (in Figs. 4B through 4D and 5B through 5D). As the dose was increased, fewer cells were positive for RacGTP, and there were fewer lamellipodia and filopodia at the leading edge (in Figs. 4B through 4D and 5B through 5D). Actin staining varied from very intense (controls and AO treatments) to less intense (Nic treatments). Single, double, and triple combinations of AOs increased RacGTP expression in HGF (in Fig. 4E through 4H ) and HPDL (in Figs. 5E through 5H) cells at the leading edge of the wound margin. The single AOs appeared to restore the level of RacGTP to control (untreated 0.1% FBS) levels in HGF (Fig. 4E) and HPDL (Fig.  5E ) cells. However, the quantification of the pixel intensity demonstrated a 60% increase in intensity in the F + Nic-treated group. The double-and triple-AO treatments increased the labeling further, with an additive effect ( Fig. 4I ; Table 4 ). The AO treated-HGF cells (in Figs. 4F through 4H) appeared to respond more than AO treated-HPDL cells (Figs. 5F through 5H; Table 5 ). The pixel-intensity analysis clearly demonstrates that the HGF cells responded more vigorously to AO treatment by increasing RacGTP expression 70% ( Fig. 4I ; Table 4 ). The RacGTP expression in all AO treated-HGF cells whether single, double, or triple, showed significant differences compared to their respective controls (P <0.05; P <0.01). Conversely, AO treated-HPDL cells (F + Nic and T + Nic) and two double-dose combinations (FT + Nic and RT + Nic) had insignificant differences among the groups compared (P <0.05; P <0.01). Moreover, for all triple-AO combinations, statistically significant group differences were found in HGF and HPDL cells (P <0.05; P <0.01).
RacGTP Expression
Because it is well known that RacGTP is necessary for cell migration, we tested the hypothesis that Nic may decrease RacGTP, and AOs may counteract this change in Rac activation.
DISCUSSION
The objective of the present study is to determine whether AOs have a counteractive effect to Nic-induced migration inhibition in HGF and HPDL cells by upregulating RacGTP at in vitro wound edges. Cell migration is a basic process involved in the morphogenesis, immunity, repair, and healing of cells and tissues of the oral cavity. 27 Nic, a major component of cigarette smoke, contributes to periodontal disease progression and slow healing after gingival and periodontal surgery. 28, 29 During wound healing, cells migrate to the site as they respond to specific chemical signals, termed chemoattractants, [30] [31] [32] to close the wound gap. 33 We first examined HGF and HPDL cells exposed to Nic to determine whether the decreases in cell viability were consistent with an inhibition of cell migration. Cells pretreated with Nic migrated more slowly than controls. The migration assays as performed may measure changes in viability as well as cell migration. The differences in cell migration after exposure to Nic were significant (P <0.05). However, most of the differences were related to changes in viability and migration because most of the assays were completed in 10 hours. Our data demonstrates that three concentrations of Nic decreased the cell viability in both cell types and were consistent with other studies (Fig. 1) . [16] [17] [18] Furthermore, this study correlates with the Nic and salivary levels in tobacco users. 34 , 35 The concentrations we tested fall within the range (0.01 to 10 mM) of Nic concentrations in saliva observed among tobacco users 17, 36 and did not induce cell death in HGF and HPDL cells. In view of these effects, we hypothesized that the use of AOs may protect the cells from further damage and may help these cells to modulate the different cellular processes such as the proliferation, secretion, and alteration of the cytoskeleton, which are all associated with a migratory phenotype. 24 Our pilot study shows no significant effects of various concentrations of AOs alone on cell migration. We showed that AOs protect HGF and HPDL cells from Nic-induced changes in migration. The decreased viability may contribute to decreased migration by providing fewer cells for migration. In HPDL cells, the single-AO treatment with R counteracted the effect of Nic on cell migration by increasing RacGTP at the leading edge. This particular AO has been extensively studied in normal and cancer cells at a variety of concentrations. In a cancercell model, R (5 mM) acted similar to estrogen by increasing lamellipodia, cell migration, and invasion in breast cancer cells. Lamellipodia were inhibited in cells that expressed dominant-negative Rac and treated with R, estrogen, or epidermal growth factor, 37 The phosphorylation of signal transducer and activator of transcription factor 3 is required for the action of R to modulate the IL-6-induced ICAM expression. This activated a transcriptional factor, tyrosine 705, in a dose-and time-dependent manner in endothelial cells. 37, 38 Oxidative stress and apoptosis were reduced after R treatment in an experimental HPDL cellhydrogen peroxide (H 2 O 2 ) injury model. It was concluded that R has a key role in protecting HPLC cells against oxidative injury. 20 Our experiments showed that a single treatment of F in HGF cells reversed the inhibitory effects of Nic on cell migration (Fig. 3) . F is a phytochemical found in many fruits and vegetables that have a broad range of therapeutic effects on human diseases. Specifically, F (10 -6 to 10 -4 M) induced angiogenesis in human umbilical vein endothelial cells in vitro without cytotoxicity as revealed by the endothelial cell-migration and tube-formation assays. This led to the conclusion that the angiogenic effect of F targeted both MAPK and PI3K pathways on endothelial cells in vitro and in vivo by modulating the expression of vascular endothelial growth factor, platelet-derived growth factor (PDGF), and hypoxia-inducible factor 1a. 39 F significantly increased the transcription of AO-related genes such as the glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase regulatory subunit, nicotinamide adenine dinucleotide phosphate (NADPH) quinone oxidoreductase-1, and heme oxygenase-1 mRNA in radiated cells, which, in turn, significantly increased the intracellular glutathione content and expression of NAPDH. RacGTP was decreased in Nic-treated cells and expressed intensely in the leading edge of AO-treated HGF cells. RacGTP (green) in white arrows was visualized in whole cells by phalloidin staining of F-actin filaments (red) at the leading edge of a scratch wound in the HGF monolayer using projected confocal microscopy z stacks projected into one image. The black void area in the center is the in vitro scratch wound in the monolayer. A) Untreated control. B through D) Six, 8, and 10 mM Nic. E) F + Nic. F) RF + Nic. G) PF + Nic. H) PFR + Nic. The mean pixel intensity (n = four fields per treatment group) was measured (I) and expressed as the percentage of mean pixel intensity compared to the untreated group (set at 100). A dose-dependent decrease in RacGTP-positive pixels was observed in Nic-treated cells (6, 8 , and 10 mM). Cells treated with Nic (6 mM) and AOs (single, double, and triple) increased RacGTP compared to untreated controls and 6 mM Nic. Scale bar = 300 mm.
F-induced nuclear factor (erythroid-derived 2)-like 2 activation to produce a cytoprotective effect against oxidative stress via PI3K and extracellularregulated kinase (ERK) signaling pathways in endothelial cells. 39 We showed that double-or triple-AO combinations were more effective than single-AO doses in counteracting Nic (Figs. 2S and 3S ). To our knowledge, this is the first report to use pure AO compounds obtained from different sources in different combinations. However, a similar study 40 that used other AOs demonstrated that double-or triple-AO combinations had a more effective AO capacity. An AO preparation of an anserine-carnosine mixture, vitamin C, and F prevented oxidative stress by ROS in human erythrocytes. 41 In a study 42 focused on blood flow in contact with reactive surfaces, AOs inhibited platelet activation by specific interactions with target proteins. In a different study 43 that examined the effects of toxic elements in smoking benzo(e)pyrene [B(e)P], combinations of genistein, R, and memantine inhibitors reversed the decreased cell viability, activation of apoptosis markers (caspase-3/7 and caspase-9) and increased the production of ROS/reactive nitrogen species in B(e)P-treated human adult retinal pigment epithelial cell-19 cultures. These inhibitors could be beneficial against retinal diseases associated with the loss of retinal pigmented epithelial cells. 43 One of the most important flavonoids derived from apples, 22 strawberries, 44 and tomatoes 45 is P. It possesses AO properties and has antiinflammatory activities in vitro by acting as a transcriptionbased inhibitor of proinflammatory gene expression in chronic inflammatory bowel disease. 46 Another study 20 made use of different parameters to demonstrate that P has anti-inflammatory and immunosuppressive effects by reducing the proliferation-related index and nitrous oxide production of the lipopolysaccharide (LPS) + interferon-g group of macrophages in T lymphocytes as well as its ability to induce a cell-cycle arrest at the Gap0/Gap1 (G0/G1) phase. A recent report 47 showed that P could promote NIH 3T3-L1 adipocyte differentiation and adiponectin expression through peroxisome proliferator-activated receptor (PPAR)-g activation. Furthermore, using microarray analysis, several genes involved in lipogenesis, triglyceride storage, and insulin signal transduction were upregulated, which indicated that P may be beneficial for reducing obesity-associated inflammation and insulin resistance. 47 The role of curcumin on wound healing and repair was shown on normal and diabetic mice. 48, 49 The 
The mean pixel intensity (n = four fields per treatment group) was measured (I) and expressed as the percentage of mean pixel intensity compared to the untreated group (set at 100). A dose-dependent decrease in RacGTP-positive pixels was observed in Nictreated cells (6, 8 , and 10 mM). Cells treated with Nic (6 mM) and AOs (single, double, and triple) increased RacGTP compared to untreated controls and 6 mM Nic. Scale bar = 300 mm.
researchers 48, 49 evaluated the efficacy of curcumin treatment by using a full-thickness punch-wound model in diabetic mice. The wounds of animals treated with curcumin showed earlier reepithelialization, improved neovascularization, increased migration of various cells, including dermal myofibroblasts, fibroblasts, and macrophages into the wound bed, and a higher collagen content. 48 Moreover, these researchers 48,50 also established a close association among curcumin, TGF-b, and the inducible nitric oxide synthase (iNOS) by using a cutaneous wound healing model. They revealed that topical application of curcumin in wound beds showed an increased expression of TGF-b1 and iNOS in dexamethasoneimpaired and -unimpaired wounds. 50 We identified some roles of pure AO compounds in this in vitro wound healing model. To support our present findings, the above-mentioned studies 20, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] summarized the multifunctional roles of these AOs when used singly, doubly, or triply, depending on the interactions of cellular and extracellular constituents. We show that the triple combination of PFR and RFT appeared to have pronounced effects on HGF and HPDL migratory potentials.
In the present study, we determined the effects of Nic on the expression of RacGTP on the edges of the scratch wound in two cell types, HGFs and HPDLs. Previous experiments showed that Nic inhibited myofibroblast differentiation 2 and affected Rac and its downstream signaling proteins in HGFs. 1 We investigated the spatial localization of RacGTP in HGF cells, which confirmed previous findings 1,2 on HGF cells (Fig. 4) . For the first time, to our knowledge, we also demonstrated the effects of Nic in RacGTP in HPDL cells in vitro (Fig. 5) . A recent study 51 showed that the Rho-family small G proteins (Rho, Rac, and Cell division cycle 42 isoform 1 [Cdc42]) upon moving are regulated in NIH3T3 cells by afadin. Afadin is an actin filament-binding protein that connects nectin to the actin cytoskeleton. A knockdown of afadin in NIH3T3 cells affected the formation of the leading edge structures and cell movement, causing inactivation of Rap1, Rac1, and RhoA in response to PDGF. 51 Transgenic mice that contained a fibroblast-specific deletion of Rac1 had delayed cutaneous wound closure, including reduced collagen production and myofibroblast formation. In vivo and in vitro, Rac1-deficient fibroblasts showed a reduced generation of ROS; in vitro, H 2 O 2 alleviated the phenotype of Rac1-deficient fibroblasts. Thus, Rac1 is an essential signaling integrator that is required for normal wound healing and dermal homeostasis. 52 The findings of the present study demonstrate that the incubation of Nic-treated HGF and HPDL cells with the single, double, and triple combinations of AOs results in a significant induction of RacGTP expression along the edges of the scratch-wound surface. The process of migration was largely dependent on integrin binding to the extracellular matrix, and many signaling molecules were involved in these processes and modified by ROS. Integrin activation was linked to increased ROS production by NADPH oxidases, 5-lipoxygenase, and the release from mitochondria. Similarly, a link between RacGTP and ROS was made in endothelial cells treated with shear stress 53 and in human lens epithelial cells and fibroblasts treated with PDGF. 54, 55 The contribution of the IL-1 receptor-associated kinase 1 (IRAK-1) to the LPS-induced generation of ROS established a link between IRAK-1 and the small GTPase Rac1, a known activator of NADPH oxidase 1 enzymatic activity. IRAK-1 forms a close complex with Rac1 via a novel LWPPPP motif within the variable region of IRAK-1. Moreover, IRAK-1 is required for LPS-mediated suppression of PPAR-a and PPAR-g coactivator, which are nuclear factors necessary for the expression of antioxidative enzymes such as glutathione peroxidase 3 and catalase. 56 In another study, 57 a connection was made among RacGTP, lamellipodia, and endothelial cell migration after treatment with high-density lipoprotein. Nic altered the activation patterns of Rac and P21 activated-kinase and upregulated p44/42 MAPK in HGF cells. 2 Some studies confirmed that Rac and Cdc42 activate p38 MAPK by negatively regulating transcription from the cyclin D1 promoter in NIH3T3 cells 58 and bovine tracheal myocytes. 59 Furthermore, high Rac activation of stress MAP kinases in bovine tracheal myocytes made it plausible to presume Rac plays a role in the stimulation and repression of several factors. Although our study focuses on the stimulatory effects of RacGTP on HGF and HPDL cells, we hope to find evidence of its role in opposing pathways. In another study, 60 the inhibition of IL-8 secretion was observed in cells preincubated with R (100 mM). Also Helicobacter pylori-induced changes were blocked in cells pretreated with R. 60 These previous studies [57] [58] [59] [60] showed the effects of R on pathogenic cells, which are specifically inhibitory, whereas in normal healthy cells, RacGTP levels in Nic-treated cells are reversed upon induction with AO.
Data from the Centers for Disease Control and Prevention found 41.3% of daily smokers >65 years of age are toothless. 61 A high percentage of current smokers affected with periodontal disease do not heal after treatment. This failure to heal can be attributed to the host immune inflammatory response and changes in vascular formation and microcirculation in periodontal tissues, 62 impaired neutrophil function, 63 decreased serum levels of IgG, 64 and suppression of inflammatory mediators. 65 In addition, an impaired healing response was observed among smokers who underwent non-surgical periodontal therapy as revealed by lesser reductions in probing depths, bleeding on probing, and a lesser gain of clinical attachment levels. 66 There are few, if any, effective therapies for these patients because the pathophysiologic processes remain poorly defined. A previous study 2 in our laboratory showed that Nic affected the healing process of gingival wounds by regulating myofibroblast as a result of downregulating the TGF-b1-induced p38 MAPK phosphorylation. In addition, the decreased cell migration in periodontal wounds exposed to Nic may be mediated through the RacGTP and P21 activated-kinase signaling pathways. 1 A combination of the tools and live imaging allowed us to delineate signaling pathways that regulate these processes that can be thought of as analogous to some TGF-b1-integrin signaling implicated in normal physiology and various pathologic processes such as chronic periodontal diseases, 67 systemic sclerosis, 68 idiopathic pulmonary fibrosis, 69 chronic obstructive pulmonary disease, 70 and cancer. 71 Moreover, TGF-b influences the integrin-mediated cell adhesion and migration by regulating the expression of integrins, their ligands, and integrin-associated proteins. More importantly, a number of integrins can interfere with both SMAD-dependent and SMAD-independent TGF-b signaling. 72 With the involvement of AOs in counteracting the negative effects of Nic, an extensive crosstalk between integrins and TGF-b signaling may take place. Some studies described a cell-surface R receptor on the extracellular domain of the heterodimeric alphaVbeta3 (avb3) integrin in Michigan Cancer Foundation-7 (MCF-7) human breast cancer cells. This receptor is linked to the induction by R of ERK1/2-and serine-15-p53-dependent phosphorylation that leads to apoptosis. The antibody to integrin avb3 inhibits the activation by R of ERK1/2 and p53, causing apoptosis in estrogen receptoralpha (ERa)-positive MCF-7 and the ERa-negative human breast adenocarcinoma cell line M.D.
Anderson-Metastatic Breast 231. 73, 74 In summary, the binding of R to the avb3 integrin is required to initiate signal-transduction mechanisms toward a p53-dependent apoptosis of breast cancer cells. 73, 74 A previous study 75 showed that a 11 b 1 is the major receptor for collagen I on mouse embryonic fibroblasts and suggested that a 11 b 1 integrin is particularly essential in PDL fibroblasts for cell migration and collagen reorganization to help generate the forces needed for axial tooth movement. Specifically, a 11 b 1 is a major collagen receptor on cultured HPDL cells, which implies that it is also functionally important in HPDLs in vivo. 76 Moreover, the expression of the avb6 integrin was downregulated in human periodontal disease and also contributed to the development of cardiovascular diseases by increasing the total systemic inflammatory burden. 67 The close association of integrins with TGF-b receptors and the control of downstream effectors may serve as potential therapeutic targets in chronic gingival and periodontal diseases.
CONCLUSIONS
Each one of the polyphenols introduced in this study possesses AO properties and performs diverse bioactivities associated with wound healing and repair. These bioactive AO compounds are linked in one way or another to a specific signaling target necessary to understand their mechanisms of action. Some of the most promising technologies we identified to date deal with the use of an engineered mammalian P-adjustable control element to program the expression of difficult-to-produce protein therapeutics during a standard bioreactor operation 77 in subcutaneous implants. This promising research could provide alternative modes of drug delivery for these pure AO compounds for future clinical trials in the treatment of chronic oral disease.
